DORZOLAMIDE

N/A

Manufactured by Indoco Remedies Limited

17,545 FDA adverse event reports analyzed

Last updated: 2026-04-14

About DORZOLAMIDE

DORZOLAMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Indoco Remedies Limited. The most commonly reported adverse reactions for DORZOLAMIDE include TREATMENT FAILURE, DRUG INEFFECTIVE, OFF LABEL USE, FATIGUE, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DORZOLAMIDE.

Top Adverse Reactions

TREATMENT FAILURE1,369 reports
DRUG INEFFECTIVE705 reports
OFF LABEL USE475 reports
FATIGUE444 reports
HEADACHE356 reports
PAIN321 reports
EYE PAIN292 reports
EYE IRRITATION281 reports
HYPERSENSITIVITY265 reports
RASH252 reports
PAIN IN EXTREMITY250 reports
CONDITION AGGRAVATED242 reports
WEIGHT DECREASED242 reports
DYSPNOEA238 reports
DIZZINESS234 reports
CONFUSIONAL STATE233 reports
DIARRHOEA221 reports
INTRAOCULAR PRESSURE INCREASED216 reports
DEATH215 reports
VISION BLURRED213 reports
PRODUCT USE IN UNAPPROVED INDICATION203 reports
SOMNOLENCE199 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION198 reports
ABDOMINAL DISCOMFORT197 reports
DEPRESSION197 reports
COVID 19192 reports
PYREXIA190 reports
NAUSEA188 reports
ASTHENIA181 reports
PRODUCT DOSE OMISSION ISSUE179 reports
PALPITATIONS177 reports
GLAUCOMA176 reports
VISUAL IMPAIRMENT176 reports
CEREBROVASCULAR ACCIDENT173 reports
DYSGEUSIA168 reports
FALL167 reports
ARTHRITIS162 reports
OCULAR HYPERAEMIA160 reports
STRESS159 reports
INTENTIONAL PRODUCT USE ISSUE157 reports
RECTAL HAEMORRHAGE153 reports
TINNITUS153 reports
VERTIGO150 reports
ACCIDENTAL OVERDOSE147 reports
HAEMATOCHEZIA147 reports
MIGRAINE147 reports
FREQUENT BOWEL MOVEMENTS146 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES145 reports
SWOLLEN TONGUE145 reports
PULMONARY EMBOLISM144 reports
DEEP VEIN THROMBOSIS143 reports
NIGHTMARE142 reports
ECZEMA141 reports
GINGIVAL PAIN138 reports
BRONCHIECTASIS136 reports
COLITIS ULCERATIVE136 reports
MEDICATION ERROR135 reports
IMPAIRED WORK ABILITY133 reports
RHINITIS133 reports
SYSTEMIC LUPUS ERYTHEMATOSUS132 reports
TUBULOINTERSTITIAL NEPHRITIS132 reports
BURNS SECOND DEGREE131 reports
CARDIAC MURMUR131 reports
HYPOPNOEA131 reports
PAROSMIA131 reports
PRURITUS129 reports
ADVERSE DRUG REACTION128 reports
CATARRH128 reports
CONSTIPATION128 reports
STEROID DEPENDENCE127 reports
IMPAIRED QUALITY OF LIFE126 reports
MALAISE119 reports
PNEUMONIA119 reports
ARTHRALGIA116 reports
COUGH114 reports
ACUTE KIDNEY INJURY113 reports
DRUG HYPERSENSITIVITY108 reports
VOMITING106 reports
GAIT DISTURBANCE99 reports
DECREASED APPETITE98 reports
EYE PRURITUS98 reports
PERIPHERAL SWELLING98 reports
CATARACT96 reports
HYPERTENSION93 reports
BACK PAIN90 reports
INCORRECT DOSE ADMINISTERED84 reports
LACRIMATION INCREASED83 reports
PRODUCT QUALITY ISSUE83 reports
ALCOHOL POISONING82 reports
INSOMNIA82 reports
BLOOD PRESSURE INCREASED81 reports
ANXIETY76 reports
URINARY TRACT INFECTION76 reports
DRY EYE75 reports
ERYTHEMA73 reports
VISUAL ACUITY REDUCED73 reports
BLINDNESS71 reports
HYPOTENSION71 reports
WEIGHT INCREASED69 reports
MUSCLE SPASMS68 reports

Report Outcomes

Out of 7,420 classified reports for DORZOLAMIDE:

Serious 47.6%Non-Serious 52.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female3,756 (54.9%)
Male3,076 (44.9%)
Unknown14 (0.2%)

Reports by Age

Age 74147 reports
Age 75131 reports
Age 80121 reports
Age 83120 reports
Age 72117 reports
Age 81117 reports
Age 84116 reports
Age 82115 reports
Age 76114 reports
Age 73109 reports
Age 77109 reports
Age 79109 reports
Age 71103 reports
Age 78102 reports
Age 6998 reports
Age 7098 reports
Age 5393 reports
Age 6793 reports
Age 8988 reports
Age 8584 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DORZOLAMIDE?

This profile reflects 17,545 FDA FAERS reports that mention DORZOLAMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DORZOLAMIDE?

Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, OFF LABEL USE, FATIGUE, HEADACHE, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DORZOLAMIDE?

Labeling and FAERS entries often list Indoco Remedies Limited in connection with DORZOLAMIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.